Cytotoxicity of a newly synthesized nitroxide derivative of 4-ferrocenecarboxyl-2,2,6,6-tetramethylpiperidine-1-oxyl in high metastatic lung tumor cells. [electronic resource]
- Die Pharmazie Dec 2006
- 1028-33 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0031-7144
Antineoplastic Agents--therapeutic use Apoptosis--drug effects Caspase 3--metabolism Caspase 8--metabolism Catalase--metabolism Cell Cycle--drug effects Cell Line, Tumor Cell Survival--drug effects Dose-Response Relationship, Drug Enzyme Activation--drug effects Ferrous Compounds--therapeutic use G1 Phase--drug effects Humans Indicators and Reagents L-Lactate Dehydrogenase--metabolism Lung Neoplasms--drug therapy Neoplasm Metastasis--pathology Piperidines--therapeutic use Superoxide Dismutase--metabolism